In late 90s, he joined Paramount Capital, serviced as an Asia/Great China Regional Director, he also provided value-added service as a venture partner & executive for a portfolio company, PolaRx Biopharma. After that, he became a China Head for business & clinical development of a public company, Cell Therapeutic, Inc  In 2002, he return to China, started his own VC firm, MCG Group and invested more than 20 biotech or healthcare related company in China and US. He is co-founder of SAPA, In his early research career He used to work for Worcester foundation and Roche Pharmaceutical He obtained BS from Zhejiang University and Ph.D.in Biomedicine from WPI in US.